A detailed history of Sawgrass Asset Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 16,891 shares of ADMA stock, worth $225,663. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,891
Previous 18,268 7.54%
Holding current value
$225,663
Previous $120,000 56.67%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$5.98 - $11.18 $8,234 - $15,394
-1,377 Reduced 7.54%
16,891 $188,000
Q1 2024

May 13, 2024

BUY
$4.4 - $6.74 $13,591 - $20,819
3,089 Added 20.35%
18,268 $120,000
Q4 2023

Feb 06, 2024

SELL
$3.08 - $4.52 $696 - $1,021
-226 Reduced 1.47%
15,179 $68,000
Q3 2023

Nov 13, 2023

BUY
$3.47 - $4.61 $53,455 - $71,017
15,405 New
15,405 $55,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.62B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.